Login / Signup

Prevalence of neurotrophic tropomyosin receptor kinase (NTRK) fusion gene positivity in patients with solid tumors in Japan.

Hiroshi TazawaTatsunori OsoneToru OgawaTomoyuki TaguchiKana HattoriShinji Kohsaka
Published in: Cancer medicine (2024)
NTRK gene fusion identification in solid tumors enables accurate diagnosis and potential TRK inhibitor therapy.
Keyphrases
  • copy number
  • genome wide
  • genome wide identification
  • risk factors
  • stem cells
  • tyrosine kinase
  • gene expression
  • risk assessment
  • binding protein
  • bioinformatics analysis